Table 1.
Descriptive analysis of the sample group.
| Clinical and demographic characteristics | |
| Men | 78.0 (51.0)*) |
| Women | 75.0 (49.0)*) |
| Age | 62.5 (11.1)** |
| Smoker | 22.0 (14.4)*) |
| Ex-smoker | 69.0 (45.1)*) |
| Non-smoker | 62.0 (40.5)*) |
| Diabetes mellitus | 55.0 (35.9)*) |
| Hypertension | 126.0 (82.4)*) |
| Family history of early-onset atherosclerosis | 39.0 (25.5)*) |
| BMI ≥30 kg/m2 | 48.0 (31.4)*) |
| Increased abdominal circumference | 107.0 (69.9)*) |
| Metabolic syndrome | 118.0 (77.1)*) |
| Statin users | 80.0 (52.3)*) |
| Laboratory data | |
| Total leukocytes >7500/mm | 73 (47.7)1 |
| Monocytes >500/mm | 69 (45.1)1 |
| Fibrinogen >350 mg/dL | 119 (79.3)2 |
| hsCRP >1 mg/L | 125 (82.8)3 |
| Low HDL-C | 105 (68.6)4 |
| Total cholesterol/HDL-C ratio <5 | 63 (41.2)4 |
| LDL-C/HDL-C ratio <3.5 | 84 (56.7)1 |
| Non-HDL-C >160 mg/dL | 57 (37.3)4 |
| NT-proBNP ≥125 pg/mL | 87 (59.8)5 |
| Abnormal ECG | 115 (75.2)4 |
| Abnormal chest radiography | 32 (21.9)6 |
| Systolic dysfunction on echocardiography | 25 (19.7)7 |
*
Number of patients (percentage); **mean (standard deviation); Index number represents the total number of patients for whom laboratory data were analyzed: 1148 patients, 2150 patients, 3151 patients, 4153 patients, 5145 patients, 6146 patients and 7127 patients. BMI - body mass index; hsCRP - high-sensitivity C-reactive protein; ECG - electrocardiogram.